[ORGANIZATION]
Etcamah
Featured in 4 tracked stories · first seen
Situations
FDA approvals for ESR1-mutated breast cancer
2 clusters · 4 sources · last updated
Latest: FDA approvals advance treatment for ESR1-mutated breast cancer
The U.S. Food & Drug Administration has expanded treatment options for hormone receptor-positive/HER2-negative metastatic breast cancer by approving therapies targeting ESR1 mutations. In September 2026, the FDA granted